Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Stathmin 1 (STMN1) is a microtubule-destabilizing protein highly expressed in hematological malignancies and involved in proliferation and differentiation. Although a previous study found that the PML-RARα fusion protein, which contributes to the pathophysiology of acute promyelocytic leukemia (APL), positively regulates STMN1 at the transcription and protein activity levels, little is known about the role of STMN1 in APL. In this study, we aimed to investigate the STMN1 expression levels and their associations with laboratory, clinical, and genomic data in APL patients. We also assessed the dynamics of STMN1 expression during myeloid cell differentiation and cell cycle progression, and the cellular effects of STMN1 silencing and pharmacological effects of microtubule-stabilizing drugs on APL cells. We found that STMN1 transcripts were significantly increased in samples from APL patients compared with those of healthy donors (all p < 0.05). However, this had no effect on clinical outcomes. STMN1 expression was associated with proliferation- and metabolism-related gene signatures in APL. Our data confirmed that STMN1 was highly expressed in early hematopoietic progenitors and reduced during cell differentiation, including the ATRA-induced granulocytic differentiation model. STMN1 phosphorylation was predominant in a pool of mitosis-enriched APL cells. In NB4 and NB4-R2 cells, STMN1 knockdown decreased autonomous cell growth (all p < 0.05) but did not impact ATRA-induced apoptosis and differentiation. Finally, treatment with paclitaxel (as a single agent or combined with ATRA) induced microtubule stabilization, resulting in mitotic catastrophe with repercussions for cell viability, even in ATRA-resistant APL cells. This study provides new insights into the STMN1 functions and microtubule dynamics in APL. © 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.


Hugo Passos Vicari, Juan Luiz Coelho-Silva, Diego A Pereira-Martins, Antônio Roberto Lucena-Araujo, Keli Lima, Jean Carlos Lipreri da Silva, Priscila Santos Scheucher, Luisa C Koury, Raul A de Melo, Rosane Bittencourt, Katia Pagnano, Elenaide Nunes, Evandro M Fagundes, Fabio Kerbauy, Lorena Lobo de Figueiredo-Pontes, Leticia Veras Costa-Lotufo, Eduardo Magalhães Rego, Fabiola Traina, João Agostinho Machado-Neto. STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells. Investigational new drugs. 2022 Apr;40(2):438-452

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 34837603

View Full Text